• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patient-Centered Approach in IBS-C Management.

作者信息

Kongara Kavita

机构信息

Motility Clinical Chair, United Digestive Georgia Physician Executive Committee Member, United Digestive Physician, Atlanta Gastroenterology Associates Atlanta, Georgia.

出版信息

Gastroenterol Hepatol (N Y). 2025 Jun;21(6):362-373.

PMID:40896757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12397800/
Abstract
摘要

相似文献

1
Patient-Centered Approach in IBS-C Management.肠易激综合征便秘型管理中的以患者为中心的方法
Gastroenterol Hepatol (N Y). 2025 Jun;21(6):362-373.
2
Irritable Bowel Syndrome肠易激综合征
3
A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome.基于微生物群的人工智能辅助个性化饮食与低可发酵寡糖、双糖、单糖和多元醇饮食的多中心随机对照试验：一种治疗肠易激综合征的新方法
Am J Gastroenterol. 2024 Sep 1;119(9):1901-1912. doi: 10.14309/ajg.0000000000002862. Epub 2024 May 8.
4
Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome.系统评价：膳食纤维与低聚半乳糖、双糖、单糖和多元醇限制饮食在便秘和肠易激综合征管理中的应用
Aliment Pharmacol Ther. 2015 Jun;41(12):1256-70. doi: 10.1111/apt.13167. Epub 2015 Apr 22.
5
Evaluation of the combined use of linaclotide and probiotics on clinical treatment efficacy and quality of life in patients with constipation-predominant irritable bowel syndrome.利那洛肽与益生菌联合使用对以便秘为主的肠易激综合征患者临床治疗效果及生活质量的评估。
Am J Transl Res. 2025 May 15;17(5):3333-3344. doi: 10.62347/GNSB4367. eCollection 2025.
6
Sentiment analysis and topic modeling of social media data to explore public discourse on irritable bowel syndrome.社交媒体数据的情感分析与主题建模，以探究关于肠易激综合征的公众讨论。
Sci Rep. 2025 Jul 1;15(1):21550. doi: 10.1038/s41598-025-08599-7.
7
A Patient-Centered Approach to Managing IBS-C and CIC.以患者为中心的 IBS-C 和 CIC 管理方法。
J Fam Pract. 2023 Jul;72(6 Suppl):S1-S6. doi: 10.12788/jfp.0514.
8
Exploring Dietitians' Perspectives Toward Current Practices and Services in Relation to Irritable Bowel Syndrome Management in Clinical Settings Across the United Kingdom: A Qualitative Study.探索英国各地临床环境中营养师对肠易激综合征管理的现行做法和服务的看法：一项定性研究。
J Acad Nutr Diet. 2025 Mar;125(3):335-347. doi: 10.1016/j.jand.2024.07.169. Epub 2024 Jul 30.
9
Effects of Probiotics and Diet Management in Patients With Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis.益生菌与饮食管理对肠易激综合征患者的影响：一项系统评价与网状Meta分析
Nutr Rev. 2025 Jan 25. doi: 10.1093/nutrit/nuae217.
10
Diagnosis and management of IBS.肠易激综合征的诊断与治疗。
Nat Rev Gastroenterol Hepatol. 2010 Oct;7(10):565-81. doi: 10.1038/nrgastro.2010.137.

本文引用的文献

1
Plecanatide Is Efficacious in Patients With Irritable Bowel Syndrome With Constipation and Bloating: Evaluation Using Trisymptom Composite Endpoints.普卡那肽对伴有便秘和腹胀的肠易激综合征患者有效：使用三症状复合终点进行评估。
Gastroenterol Hepatol (N Y). 2024 Dec;20(12 Suppl 9):12-13.
2
Irritable Bowel Syndrome With Constipation Poses a Substantial Burden to Patient Overall Health Status and Quality of Life: Results From the IBS in America 2024 Real-World Survey.便秘型肠易激综合征对患者整体健康状况和生活质量构成重大负担：2024年美国肠易激综合征真实世界调查结果
Gastroenterol Hepatol (N Y). 2024 Dec;20(12 Suppl 9):2-3.
3
Managing IBS-C: Focus on Symptom Control.管理便秘型肠易激综合征：关注症状控制。
Gastroenterol Hepatol (N Y). 2024 Apr;20(4):216-226.
4
Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.普卡必利改善便秘型肠易激综合征的腹胀和肠道症状。
Dig Dis Sci. 2024 May;69(5):1731-1738. doi: 10.1007/s10620-024-08330-y. Epub 2024 Apr 9.
5
Mechanism of Action Considerations in the Management of IBS-C.IBS-C管理中的作用机制考量
Gastroenterol Hepatol (N Y). 2023 Dec;19(12):749-756.
6
Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.替那诺尔治疗便秘型肠易激综合征患者临床试验期间的腹部症状改善：一项事后分析
Am J Gastroenterol. 2024 May 1;119(5):937-945. doi: 10.14309/ajg.0000000000002685. Epub 2024 Jan 31.
7
Differential Diagnosis of Chronic Diarrhea: An Algorithm to Distinguish Irritable Bowel Syndrome With Diarrhea From Other Organic Gastrointestinal Diseases, With Special Focus on Exocrine Pancreatic Insufficiency.慢性腹泻的鉴别诊断：一种用于区分腹泻型肠易激综合征与其他器质性胃肠道疾病的算法，特别关注外分泌胰腺功能不全。
J Clin Gastroenterol. 2023 Aug 1;57(7):663-670. doi: 10.1097/MCG.0000000000001855.
8
Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.便秘型肠易激综合征（IBS-C）：不同营养模式对肠道菌群失调和症状的影响。
Nutrients. 2023 Mar 28;15(7):1647. doi: 10.3390/nu15071647.
9
Approach to Disorders of Gut-Brain Interaction.肠道-脑相互作用障碍的处理方法
Mayo Clin Proc. 2023 Mar;98(3):458-467. doi: 10.1016/j.mayocp.2022.11.001.
10
The neurobiology of irritable bowel syndrome.肠易激综合征的神经生物学。
Mol Psychiatry. 2023 Apr;28(4):1451-1465. doi: 10.1038/s41380-023-01972-w. Epub 2023 Feb 2.